Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3075% below fair value
$1.51+0.15 (+11.03%)
Close on Nov 13, 2026Market cap $113.64MP/E –Yield –
Health Catalyst enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Health Catalyst's enterprise value was $156.72M on Nov 11, 2026, against $272.76M a year earlier. Over the last 5 years it ranged from $123.68M to $1.60B, with a median of $304.92M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $156.72M | -32.0% |
| 2025 | Dec 31, 2025 | $230.39M | -40.6% |
| 2024 | Dec 31, 2024 | $387.97M | -5.0% |
| 2023 | Dec 29, 2023 | $408.19M | -3.3% |
| 2022 | Dec 30, 2022 | $422.30M | -73.6% |
| 2021 | Dec 31, 2021 | $1.60B | -7.5% |
| 2020 | Dec 31, 2020 | $1.73B | +61.3% |
| 2019 | Dec 31, 2019 | $1.07B | – |
See a number that looks wrong?